Verified Nov 2026
Other
·

Cambridge, England
·
Since 2012
Cycle Pharmaceuticals is a privately-held biotechnology company headquartered in Cambridge, England, founded in 2012, with 100–200 employees and estimated revenue of $10–50M. It develops treatments for rare genetic diseases including metabolic, neurological, and immunological conditions across medical and related sectors. The company launched CAVHANZA (nilotinib) in the United States in August 2026 and completed acquisition of Applied Therapeutics in February 2026.
Cycle Pharmaceuticals at a glance
Revenue
$10-50M
Est. band
Employees
100-200
Founded
2012
Headquarters
Cambridge, England
Industries
Automotive
Electric Vehicles
Medical
Overview
Cycle Pharmaceuticals is a privately-held biotechnology company headquartered in Cambridge, England, founded in 2012, with 100–200 employees and estimated revenue of $10–50M. It develops treatments for rare genetic diseases including metabolic, neurological, and immunological conditions across medical and related sectors. The company launched CAVHANZA (nilotinib) in the United States in August 2026 and completed acquisition of Applied Therapeutics in February 2026.
At a glance
Attribute | Detail |
|---|---|
Founded | 2012 |
Headquarters | Cambridge, England |
Employees | 100-200 |
Revenue | $10-50M (estimated) |
What Cycle Pharmaceuticals makes
The company specializes in orphan drug development, drug repurposing, and generic formulations, with a portfolio addressing conditions such as phenylketonuria, tyrosinemia, alkaptonuria, and multiple sclerosis.
Products and capabilities described on the company's own site include Pump (source: cyclepharma.com).
Latest developments
2026-08-24 — Cycle Pharmaceuticals launches CAVHANZA for patients in the US (cyclepharma.com)
2026-08-12 — Cycle Pharmaceuticals Selects Forma Life Sciences to Establish U.S. Commercial Supply for FDA-Approved CAVHANZA™ (nilotinib) Orally Disintegrating Tablets (businesswire.com)
2026-02-03 — Cycle Pharmaceuticals Completes Acquisition of Applied Therapeutics - Cycle Pharma (cyclepharma.com)
2025-10-16 — Cycle Pharma launches PHYRAGO™ (dasatinib) tablets (cyclepharma.com)
2025-07-21 — Cycle Pharmaceuticals Selects LeMed Specialty Pharmacy as Exclusive U.S. Specialty Pharmacy Distribution and Services Partner for HARLIKU™ (nitisinone) Tablets — the First and only FDA-approved Treatment for Adult Patients with Alkaptonuria (AKU) (businesswire.com)
2025-07-21 — Cycle Pharma Signs Exclusive License for PHYRAGO™ (dasatinib) Tablets (cyclepharma.com)
Facilities
Cycle Pharmaceuticals is headquartered in Cambridge, England. Public sources also reference these locations:
Irvine, California — linkedin.com
Company details
Cycle Pharmaceuticals operates with a patient-centric model offering free medications in countries unable to afford them and provides comprehensive patient support including dietary supplements and personalized care. Cycle Pharmaceuticals was founded in 2012, has an estimated 100-200 employees, and is headquartered in Cambridge, England.
Frequently asked questions
What does Cycle Pharmaceuticals do?
Cycle Pharmaceuticals is a privately-held biotechnology company headquartered in Cambridge, England, founded in 2012, with 100–200 employees and estimated revenue of $10–50M. It develops treatments for rare genetic diseases including metabolic, neurological, and immunological conditions across medical and related sectors. The company launched CAVHANZA (nilotinib) in the United States in August 2026 and completed acquisition of Applied Therapeutics in February 2026.
Where is Cycle Pharmaceuticals headquartered?
Cycle Pharmaceuticals is headquartered in Cambridge, England (J J Thomson Avenue, Cambridge, England, CB3 0).
When was Cycle Pharmaceuticals founded?
Cycle Pharmaceuticals was founded in 2012.
How big is Cycle Pharmaceuticals?
Cycle Pharmaceuticals has an estimated 100-200 employees, with revenue in the $10-50M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
